Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0MGBXM
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
CD38-077
|
|||||
| Synonyms |
CD38 077; CD38077
Click to Show/Hide
|
|||||
| Organization |
Concortis Biosystems Corp.
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 2 Indication(s)
Burkitt lymphoma [ICD11:2A85]
Clinical candidate
Multiple myeloma [ICD11:2A83]
Clinical candidate
|
|||||
| Antibody Name |
STI-5171
|
Antibody Info | ||||
| Antigen Name |
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (CD38)
|
Antigen Info | ||||
| Payload Name |
Duostatin 5.2
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Non-polyethylene glycol linker
|
Linker Info | ||||
| Conjugate Type |
Site-specific conjugation proprietary C-LOCK technology.
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.